| | |||||
| lose weight | |||||
| NEWS | |||||
| Adults with obesity lost 22.7% of body weight with combination GLP-1/amylin analog Key takeaways: CagriSema induced superior weight loss compared with placebo for adults with obesity in the REDEFINE 1 trial. The medication's safety ...
| |||||
| Older, cost-effective anti-obesity medications maintain weight loss after GLP-1 therapy Participants enrolled in a GLP-1 receptor agonist weight-loss program maintained their weight loss at long-term follow-up after transitioning to ...
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |